• Health & Medicine

Immune cell count could determine whether chemotherapy is required in oropharyngeal cancer, new study finds 

A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer. A new study has found that the level of a person's immune cells may provide an indication of whether they would benefit from chemotherapy in oropharyngeal cancer.

2 May 2022

• Health & Medicine

New insights on self-sampling for cervical cancer screening

Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician. Results have revealed that around half of those eligible would prefer self-sampling for cervical screening over being tested by a clinician.

27 April 2022

• Health & Medicine

New study identifies how obesity may increase the risk of developing womb cancer

Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine. Lifelong excess weight almost doubles a woman’s risk of developing womb cancer, according to a Cancer Research UK-funded study published in BMC Medicine.

19 April 2022

• Science & Technology

A urine test for bladder cancer: What’s the latest?

Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in. Less than a year after The University of Birmingham had partnered with Nonacus to produce a urine test for bladder cancer, the first results are in.

16 April 2022

• Health & Medicine

Triple negative breast cancer drug given initial ‘no’ for NHS in England

Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer. Sacituzumab govitecan (Trodelvy) is not being recommended by NICE for use in England as a treatment for some people with triple-negative breast cancer.

8 April 2022

• Science & Technology

Personalised blood test could help predict which lung cancers might return

Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test. Our researchers at the University of Cambridge have found that patients who are at a higher risk of their lung cancer returning can be identified by a personalised blood test.

1 April 2022

• Health & Medicine

Is there a right way to check your body for cancer? 

There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking. There’s no ‘right’ way to check certain parts of your body for cancer, but here’s what you need to keep in mind when self-checking.

29 March 2022

• Science & Technology

Piecing together the puzzle: Antibiotics, the microbiome and bowel cancer

Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play. Our researchers across the world are investigating a potential link between bowel cancer and the microbiome, and the potential role antibiotics might play.

15 March 2022

• Science & Technology

Paving the way: How biopsies are offering hope to children with aggressive brain tumours

7 March 2022

• Health & Medicine

Reduction in women screened for breast cancer between 2020 and 2021, NHS report finds

A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic. A new report by NHS Digital reveals how breast screening services were impacted during the COVID-19 pandemic.

25 February 2022

• Health & Medicine

No link between breast pain alone and cancer diagnosis, study finds

Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms. Research finds women with breast pain alone were no more to receive a diagnosis of breast cancer than women with no symptoms.

22 February 2022

• Science & Technology

Advanced MRI could help to differentiate aggressive and slower growing prostate cancer

New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways. New research has found that using an advanced MRI technique may enable doctors to pinpoint potentially aggressive or fast-growing cancers and guide treatment pathways.

14 February 2022